联合健康
UNH
401.43
-5.24
-1.29%
联合健康
US · UNH
#44 按市值排名
上市于 1984
401.43
-5.24
-1.29%
实时 - 追踪5344个代码 - 心跳于172秒前
· 2026-10-16 19:59
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了17家。
- 机构持股总比例上升了0.6个百分点。
机构持股
- 机构持股比例
- 89.21% +0.61pp
- 机构数量
- 3,917 -17
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund74.79%
Public Company4.59%
Private Company2.57%
Hedge Fund2.31%
Government Pension Fund2.30%
Sovereign Wealth Fund1.51%
Family Office/Trust0.35%
Insurance Company0.30%
VC/PE Fund0.20%
Other11.09%
主要股东 截至 2026-06-30
BlackRock
8.56% · 76.86M 股
Vanguard Capital Management, LLC
7.18% · 64.41M 股
Capital Research
5.42% · 48.61M 股
State Street Global Advisors
5.08% · 45.63M 股
Vanguard Portfolio Management, LLC
2.73% · 24.48M 股
Other
71.03%
T. Rowe Price Group, Inc.
2.66% · 23.84M 股
FMR
2.54% · 22.76M 股
Geode Capital Management, LLC
2.42% · 21.75M 股
Charles Schwab Investment Management
2.21% · 19.83M 股
J.P. Morgan Asset Management, Inc.
1.50% · 13.45M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 46次买入 · 4次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Stephen Hemsley | Non-Independent Non-Executive Chairperson | 0.12% |
| John Rex | Chief Financial Officer | 0.02% |
| Andrew Witty | Chief Executive Officer | 0.01% |
| Thomas Roos | Chief Accounting Officer | 0.00% |
| Wayne DeVeydt | Chief Financial Officer | 0.00% |
| Heather Cianfrocco | President of Optum | 0.00% |
| Timothy Noel | Chief Executive Officer of UnitedHealthcare Medicare & Retirement | 0.00% |
| Christopher Zaetta | Executive Vice President | 0.00% |
| Erin L. McSweeney | Executive VP & Chief People Office | 0.00% |
| Dennis Stankiewicz | Chief Accounting Officer | 0.00% |
| Frederick McNabb | Independent Director | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Paul Garcia | Independent Director | Other Acquisition | +103 | -- |
| 2026-09-30 | Paul Garcia | Independent Director | Other Acquisition | +155 | -- |
| 2026-09-30 | Timothy Flynn | Independent Director | Other Acquisition | +262 | -- |
| 2026-09-30 | Charles Baker | Independent Director | Other Acquisition | +257 | -- |
| 2026-09-30 | Frederick McNabb | Independent Director | Other Acquisition | +291 | -- |
| 2026-09-30 | Scott Gottlieb | Director | Other Acquisition | +257 | -- |
| 2026-09-30 | John Noseworthy | Independent Director | Other Acquisition | +240 | -- |
| 2026-09-30 | Valerie C. Rice | Independent Director | Other Acquisition | +257 | -- |
| 2026-09-30 | Kristen Gil | Independent Director | Other Acquisition | +240 | -- |
| 2026-09-21 | Stephen Hemsley | Non-Independent Non-Executive Chairperson | Other Acquisition | +50 | -- |
| 2026-09-21 | Paul Garcia | Independent Director | Other Acquisition | +16 | -- |
| 2026-09-21 | Timothy Flynn | Independent Director | Other Acquisition | +68 | -- |
| 2026-09-21 | Charles Baker | Independent Director | Other Acquisition | +15 | -- |
| 2026-09-21 | Frederick McNabb | Independent Director | Other Acquisition | +57 | -- |
| 2026-09-21 | Wayne DeVeydt | Chief Financial Officer | Other Acquisition | +106 | -- |
| 2026-09-21 | Scott Gottlieb | Director | Other Acquisition | +5 | -- |
| 2026-09-21 | John Noseworthy | Independent Director | Other Acquisition | +46 | -- |
| 2026-09-21 | Valerie C. Rice | Independent Director | Other Acquisition | +47 | -- |
| 2026-09-21 | Erin L. McSweeney | Executive VP & Chief People Office | Other Acquisition | +53 | -- |
| 2026-09-21 | Patrick Conway | Chief Executive Officer of Optum Rx | Other Acquisition | +91 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:59:41 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
medical cost ratio finally stabilizing after a rough stretch, this name went from market darling to cautionary tale faster than almost anything I’ve watched in healthcare.